ANI Pharmaceuticals Inc. (ANIP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ANI Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$71.71
+0.76% today
Market cap
$1.6B
Overall quality
69/100
Kronos AI 30-day
+10.0%
8 of 8 simulated paths end higher
ANI Pharmaceuticals Inc. (ANIP) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.6B. It trades at $71.71, up 0.76% today, at 16.5 times earnings. Its overall quality score is 69 out of 100, ranked against the whole US market. 7 analysts' average target of $106.75 implies +48.9% from today's price. Kronos AI's 30-day forecast is +10.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $106.75 |
| Low – high | $85.00 – $121.00 |
| Analysts | 7 |
| Upside to average | +48.9% |
Kronos AI 30-day forecast
| Expected close | $78.26 (+10.0%) |
| Likely range | +5.2% … +15.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 75 |
| Solvency | 43 |
| Growth | 89 |
| Overall | 69 |
| P/E | 16.5 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.